Jazz Argues Drug Patent Should Stay In Orange Book

By Kelly Lienhard · February 14, 2023, 9:43 PM EST

Jazz Pharmaceuticals tried to convince the Federal Circuit in oral arguments on Tuesday to overturn a lower court order to remove its patent for its narcolepsy drug from the Food and Drug...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC

Case Number

23-1186

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

November 28, 2022